Vanguard Group Inc Pa Vmed Inc. Transaction History

Vanguard Group Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.22 - $0.5 $22,855 - $51,945	103,890 Added 2.81%	3,806,574 $1.14 Million
Q4 2022 Feb 10, 2023	BUY	$0.41 - $1.1 $729 - $1,956	1,779 Added 0.05%	3,702,684 $1.78 Million
Q3 2022 Nov 14, 2022	BUY	$0.57 - $1.77 $134,775 - $418,512	236,448 Added 6.82%	3,700,905 $3.18 Million
Q2 2022 Aug 12, 2022	SELL	$0.85 - $1.41 $639,646 - $1.06 Million	-752,525 Reduced 17.85%	3,464,457 $3.24 Million
Q1 2022 May 13, 2022	BUY	$1.16 - $2.5 $135,716 - $292,492	116,997 Added 2.85%	4,216,982 $5.57 Million

Q4 2021 Feb 14, 2022	SELL	$2.46 - $8.74 $157,526 - $559,665	-64,035 Reduced 1.54%	4,099,985 $10.1 Million
Q3 2021 Nov 12, 2021	BUY	$5.1 - $9.39 $647,480 - $1.19 Million	126,957 Added 3.14%	4,164,020 $35.6 Million
Q2 2021 Aug 13, 2021	BUY	$3.95 - $6.88 $15.9 Million - $27.8 Million	4,037,063 New	4,037,063 $25.8 Million

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $74.6M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.